ZBH | tickerfilter.com

Fundamental analysis

43%

Profitability 43%

Dept financing 45%

Liquidity 14%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.53%

1 Month

4.09%

3 Months

-1.03%

6 Months

0.71%

1 Year

-14.01%

2 Year

-16.12%

Key data

Stock price

$107.80

P/E Ratio

20.27

DAY RANGE

$107.69 - $108.82

EPS

$5.23

52 WEEK RANGE

$100.67 - $133.90

52 WEEK CHANGE

-$15.48

MARKET CAP

21.935 B

YIELD

0.89%

SHARES OUTSTANDING

203.652 M

DIVIDEND

$0.24

EX-DIVIDEND DATE

06/26/2024

NEXT EARNINGS DATE

N/A

BETA

0.51

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,554,207

AVERAGE 30 VOLUME

$1,789,488

Company detail

CEO: Bryan C. Hanson
Region: US
Website: zimmerbiomet.com
Employees: 18,000
IPO year: 2001

Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Zimmer Biomet Holdings, Inc. operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products.

ZBH - ZIMMER BIOMET HOLDINGS, INC.